Anticancer, Ru(II) complexes, X-ray crystal structures, Cytotoxicity, DNA binding, Fluorescence lifetime
Iron-cyclopentadienyl, ABCB1 inhibitor, cancer multidrug resistance, colon adenocarcinoma